Reaktionsgleichung
[CH2:1]([O:3][C:4]([C:6]1[NH:14][C:9]2=[N:10][CH:11]=[CH:12][CH:13]=[C:8]2[CH:7]=1)=[O:5])[CH3:2].CC(C)([O-])C.[K+].[C:21]([O:25][C:26]([N:28]1[CH2:32][C@H:31]([CH3:33])OS1(=O)=O)=[O:27])([CH3:24])([CH3:23])[CH3:22]>>[CH2:1]([O:3][C:4]([C:6]1[N:14]([C@H:31]([CH3:33])[CH2:32][NH:28][C:26]([O:25][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:27])[C:9]2=[N:10][CH:11]=[CH:12][CH:13]=[C:8]2[CH:7]=1)=[O:5])[CH3:2]Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
This compound was prepared in analogy to Example 1 intermediate a), from 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester, potassium tert-butoxide and (S)-5-methyl-2,2-dioxo-[1,2,3]oxathiazolidine-3-carboxylic acid tert-butyl ester.
Quellen und Nachweise
- ORD-Eintrag
- ord-3096397b79924ba2b3dce04ecbaf743c
- Quelldatensatz
- uspto-grants-2006_08
- Patentnummer
- US07098337B2
Verknüpfte Notizen
Wird geladen…